Bead-Linked Transposome Tagmentation for Vector Integration Site Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing integration sites of vectors in genomes are complex, time-consuming, and require large amounts of DNA, making them unsuitable for rapid and large-scale clinical applications, especially in gene therapy where quick and efficient analysis is crucial.

Innovation Solution

The method involves performing tagmentation using a bead-linked transposome and optimizing PCR conditions to simplify and expedite the analysis of quantitative integration sites of vectors in genomes, allowing for the detection of integration sites and quantification of clones with a smaller DNA sample.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional methods (LAM-PCR, nrLAM-PCR, LM-PCR) are used for integration site analysis, then measurement precision and reliability are improved, but device complexity and analysis time increase significantly

Engineering Contradiction:
Improveintegration site detection accuracyVSAvoidmethod complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The method segments the integration site analysis into distinct stages: tagmentation with bead-linked transposomes for fragmentation and adapter tagging, followed by simplified PCR amplification. This segmentation allows each step to be optimized independently, reducing overall complexity while maintaining precision.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces bead-linked transposomes as an intermediary tool that combines fragmentation and adapter tagging functions in a single reagent system. This intermediary eliminates the need for separate restriction enzyme digestion and linker ligation steps required by conventional methods, thereby reducing procedural complexity.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If conventional methods are used for integration site analysis, then measurement precision is improved, but loss of time increases

Engineering Contradiction:
Improveintegration site detection accuracyVSAvoidanalysis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The bead-linked transposomes are pre-prepared with adapters attached to the beads before use. This preliminary action eliminates the need for in-situ adapter ligation during the analysis procedure, reducing the overall analysis time while maintaining detection precision.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The method merges fragmentation and adapter tagging into a single tagmentation step performed simultaneously by the bead-linked transposome. This consolidation of multiple steps into one operation significantly reduces the time required compared to sequential conventional methods.

Inventive Principle:
Principle #5Merging (Combining)

3Measurement precision

If conventional methods are used for integration site analysis, then measurement precision is improved, but quantity of substance required increases

Engineering Contradiction:
Improveintegration site detection accuracyVSAvoidDNA input amount
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent changes the physical parameters of the transposome system by linking it to magnetic beads, which enables efficient capture and concentration of DNA fragments. This parameter change allows the method to achieve high precision with lower DNA input amounts compared to conventional solution-based methods.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The bead-linked transposome acts as an intermediary that concentrates DNA fragments during the tagmentation process. The magnetic beads provide a surface for efficient DNA binding and concentration, reducing the total DNA quantity needed while maintaining detection sensitivity.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Productivity

If rapid analysis is performed with tagmentation method, then productivity is improved, but manufacturing precision may worsen

Engineering Contradiction:
Improveanalysis speedVSAvoidintegration site detection accuracy
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent optimizes the tagmentation reaction parameters including temperature, time, and transposome-to-DNA ratio to achieve both rapid processing and high precision. By carefully controlling these parameters, the method maintains manufacturing precision while improving productivity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The method replaces complex mechanical manipulation steps (multiple pipetting, ligations, and purifications) with a simplified tagmentation-PCR workflow that relies on biochemical reactions. This substitution reduces manual errors and maintains precision while accelerating the process.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables rapid and efficient analysis of integration sites, improving the monitoring of safety and effectiveness of gene therapy agents like CAR-T cells, and accommodating the need for high-throughput analysis with limited DNA samples.

Implementation Method 1

performing tagmentation using a bead-linked transposome

Methodology Applied
Scientific EffectTagmentation:

Data Source

PatentUS20250154501A1Method for vector insertion site detection and clonal quantification using tagmentation
Publication Date: 2025.05.15 SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
  • US20250154501A1 patent drawing
  • US20250154501A1 patent drawing
  • US20250154501A1 patent drawing

AI summary

The present disclosure relates to a method of detecting an integration site of a vector in a genome. According to the method of the present disclosure, it is possible to simply and quickly analyze a quantitative integration site of a viral vector with respect to a plurality of DNA motifs (sites) in a genome. Therefore, it can be useful for monitoring the safety and effectiveness of a gene therapy agent.